Infiltration of SIGLEC1+ macrophages in colorectal cancer was associated with tumor progression, but in hepatocellular carcinoma they predicted favorable patient outcomes (Zhang et al., 2016), underpinning the hypothesis that TAM phenotypes/activation are organ and cancer specific. The gene discussed is SIGLEC1; the disease is hepatocellular carcinoma.